Case Report of Serum Sickness-like Reaction following the First Dose of the Chimpanzee Adenovirus-Vectored AstraZeneca COVID-19 Vaccine, ChAdOx1 [PDF]
Vaccines, 2023 Serum sickness-like reaction from serum sickness is critical. Serum sickness-like reaction has comparable symptoms to serum sickness, but their underlying pathophysiology is distinct.
Areej Awad Alzaidi +3 more
doaj +2 more sources
Case Report: Serum sickness induced by dupilumab—clinical insights and Olinkproteomic analysis [PDF]
Frontiers in ImmunologyDupilumab is a humanized monoclonal antibody that targets interleukin-4 (IL-4) and IL-13 pathways, commonly used in the treatment of various inflammatory conditions.
Hongguo Zhu +4 more
doaj +2 more sources
Case Report: Use of Obinutuzumab as an Alternative Monoclonal Anti-CD20 Antibody in a Patient With Refractory Immune Thrombocytopenia Complicated by Rituximab-Induced Serum Sickness and Anti-Rituximab Antibodies [PDF]
Frontiers in Immunology, 2022 Management of refractory immune thrombocytopenia frequently involves rituximab, a chimeric anti-CD20 monoclonal antibody, to target B cells and induce remission in most patients.
Jennifer R. Blase +3 more
doaj +2 more sources
Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report [PDF]
Clinical Case Reports, 2021 Serum sickness, a reaction presenting with a classic triad (fever, rash, myalgia/arthralgia), is considered as a rare adverse event following monoclonal antibodies and specifically following treatment with rituximab. This report describes a case of serum
Mohamad Y. Khatib +2 more
doaj +2 more sources
Rituximab‐induced serum sickness in immunobullous disorders: A case series [PDF]
Clinical Case ReportsKey Clinical Message Rituximab‐induced serum sickness (RISS) is a rare complication of Rituximab (RTX) in immunobullous disorders. Clinicians should be aware of the occurrence of serum sickness symptoms during RTX administration, and prompt initiation of
Mehdi Gheisari +3 more
doaj +2 more sources
Rituximab-induced serum sickness in progressive transformation of germinal centers immunoglobulin G4-related disease: a case report [PDF]
Journal of Medical Case ReportsIntroduction Serum sickness, a type III hypersensitivity reaction, can arise from various triggers such as vaccines, anti-venoms, and certain medications, particularly monoclonal antibodies.
Sharanya Kumar +4 more
doaj +2 more sources
Serum Sickness following Tetanus Toxoid Injection [PDF]
Case Reports in Pediatrics, 2021 Serum sickness is an allergic reaction that frequently occurs in patients after the injection of foreign protein or serum. It is characterized by fever, skin rash, enlarged lymph nodes, and painful joints.
Saja alhawal +2 more
doaj +2 more sources
A rare manifestation of serum sickness after common krait envenomation in a patient treated with polyvalent anti-snake venom in India: Presentation and challenges [PDF]
Journal of Family Medicine and Primary CareEnvenomation from snakebites is a significant public health concern in the Southeast Asian region resulting in considerable mortality and morbidity. Anti-snake venom (ASV) despite being the only rescue can bring forth several acute and delayed adverse ...
Satyabrata Guru +4 more
doaj +2 more sources
A case of pediatric serum sickness like reaction (SSLR) after a 2-month re-exposure to amoxicillin [PDF]
Allergy, Asthma & Clinical ImmunologyBackground Serum-sickness like reactions (SSLRs) to amoxicillin have been documented in the medical literature. Beta-lactams are important and commonly used medications especially in the pediatric population.
Devyani Bakshi +2 more
doaj +2 more sources
Serum sickness-like reaction to D-mannose supplement: a case report [PDF]
BMC PediatricsBackground Serum Sickness-Like Reaction (SSLR) is an immune response characterized by rash, polyarthralgias, inflammation, and fever. Serum sickness-like reaction is commonly attributed to antibiotics, anticonvulsants, and anti-inflammatory agents.
Emma R. Plante +3 more
doaj +2 more sources